|
Keating C, Pelegrin P, Martínez CM, Grundy D. P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome. J Immunol. 2011 Aug 1;187(3):1467-74. doi: 10.4049/jimmunol.1100423. Epub 2011 Jun 22. PubMed PMID: 21697458.
AÑO: 2011; IF: 5.788
|
21697458
|
Roger S, Gillet L, Baroja-Mazo A, Surprenant A, Pelegrin P. C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem. 2010 Jun 4;285(23):17514-24. doi: 10.1074/jbc.M109.053082. Epub 2010 Apr 8. PubMed PMID: 20378545; PubMed Central PMCID: PMC2878516.
AÑO: 2010; IF: 5.328
|
|
Lopez-Castejon G, Theaker J, Pelegrin P, Clifton AD, Braddock M, Surprenant A. P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol. 2010 Aug 15;185(4):2611-9. doi: 10.4049/jimmunol.1000436. Epub 2010 Jul 16. PubMed PMID: 20639492.
AÑO: 2010; IF: 5.745
|
|
Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 2009 Jul 22;28(14):2114-27. doi: 10.1038/emboj.2009.163. Epub 2009 Jun 18. PubMed PMID: 19536133; PubMed Central PMCID: PMC2699392.
AÑO: 2009; IF: 8.993
|
|
Ma W, Hui H, Pelegrin P, Surprenant A. Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther. 2009 Feb;328(2):409-18. doi: 10.1124/jpet.108.146365. Epub 2008 Nov 20. PubMed PMID: 19023039; PubMed Central PMCID: PMC2682283.
AÑO: 2009; IF: 4.093
|